Stockscreener 앱 받기
0.441
4.15%
-0.0191
시간 외 거래:
.44
-0.001
-0.23%
전일 마감가:
$0.4601
열려 있는:
$0.44
하루 거래량:
1.83M
Relative Volume:
0.52
시가총액:
$51.31M
수익:
-
순이익/손실:
$-119.76M
주가수익비율:
-0.3267
EPS:
-1.35
순현금흐름:
$-55.17M
1주 성능:
-15.73%
1개월 성능:
-13.26%
6개월 성능:
-94.74%
1년 성능:
-93.08%
1일 변동 폭
$0.435
$0.4641
1주일 범위
$0.435
$0.5598
52주 변동 폭
$0.435
$10.62
Applied Therapeutics Inc Stock (APLT) Company Profile
명칭
Applied Therapeutics Inc
전화
212-220-9226
주소
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
APLT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
APLT
Applied Therapeutics Inc
|
0.441 | 51.31M | 0 | -119.76M | -55.17M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.49 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
625.60 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
583.62 | 35.60B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
266.83 | 34.53B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
274.78 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-23 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-12-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-11-29 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-07-31 | 개시 | William Blair | Outperform |
| 2024-03-26 | 개시 | RBC Capital Mkts | Outperform |
| 2024-02-22 | 개시 | Leerink Partners | Outperform |
| 2022-01-04 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2021-08-27 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-06-25 | 재개 | Goldman | Neutral |
| 2020-10-08 | 개시 | Truist | Buy |
| 2020-04-22 | 개시 | Goldman | Buy |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2019-06-10 | 개시 | Citigroup | Buy |
| 2019-06-10 | 개시 | Cowen | Outperform |
| 2019-06-10 | 개시 | Robert W. Baird | Outperform |
모두보기
Applied Therapeutics Inc 주식(APLT)의 최신 뉴스
Applied Therapeutics Delays Yearly Report Filing - TipRanks
Applied Therapeutics files Form 12b-25 with SEC - TipRanks
Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission - GlobeNewswire
Applied Therapeutics Requests SEC Extension: What This Means for 2024 Financial Results - Stock Titan
146,900 Shares in Applied Therapeutics, Inc. (NASDAQ:APLT) Purchased by Swiss National Bank - Defense World
Shareholders of Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT - ACCESS Newswire
Lost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Applied Therapeutics, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT - ACCESS Newswire
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
Applied Therapeutics appoints new Chief Regulatory Officer By Investing.com - Investing.com South Africa
Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer - citybiz
APLT DEADLINE ALERT: Applied Therapeutics Investors have until February 18 before Expiration of the Class Action DeadlineContact BFA Law if You Lost Money - Louisiana First News
Applied Therapeutics Names Todd Baumgartner As Chief Regulatory Officer - Nasdaq
Applied Therapeutics appoints new Chief Regulatory Officer - Investing.com
Applied Therapeutics Strengthens Drug Approval Push With 12-Time FDA Success Veteran - Stock Titan
Brokerages Set Applied Therapeutics, Inc. (NASDAQ:APLT) Price Target at $6.10 - MarketBeat
Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your RightsAPLT - ACCESS Newswire
Applied Therapeutics, Inc. (NASDAQ:APLT) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
APPLIED THERAPEUTICS Earnings Preview: Recent $APLT Insider Trading, Hedge Fund Activity, and More - Nasdaq
A look into Applied Therapeutics Inc (APLT)’s deeper side - SETE News
Applied Therapeutics Inc (APLT) Announces Year-End 2023 Financia - GuruFocus.com
40,300 Shares in Applied Therapeutics, Inc. (NASDAQ:APLT) Purchased by Private Advisor Group LLC - Defense World
Shareholders of Applied Therapeutics, Inc. Should Contact The Gr - GuruFocus.com
Applied Therapeutics, Inc. Class Action: Levi & Korsinsky Remind - GuruFocus.com
Applied Therapeutics (APLT) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Applied therapeutics’ interim CEO sells shares worth $6,380 - Investing.com India
Applied Therapeutics chief medical officer sells shares worth $4,561 - Investing.com India
Applied therapeutics COO Constantine Chinoporos sells $196 in stock - Investing.com
Applied Therapeutics chief medical officer sells shares worth $4,561 By Investing.com - Investing.com UK
Monitoring Applied Therapeutics Inc (APLT) after recent insider movements - Knox Daily
APLT Deadline: APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit - GuruFocus.com
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics - GuruFocus.com
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc. (APLT) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Class Action Filed Against Applied Therapeutics, Inc. (APLT)February 18, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
APLT stock touches 52-week low at $0.49 amid sharp annual decline - Investing.com India
APLT stock touches 52-week low at $0.49 amid sharp annual decline By Investing.com - Investing.com South Africa
Applied Therapeutics (APLT) to Release Earnings on Wednesday - Defense World
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Applied Therapeutics (APLT) Projected to Post Earnings on Wednesday - MarketBeat
Applied Therapeutics, Inc. Investigated Regarding Potential Securities Law ViolationsContact Levi & Korsinsky for DetailsAPLT - ACCESS Newswire
Market Fluctuations Drive Mega-Cap, Large-Cap, Mid-Cap, and Small-Cap Stocks in Wild Movements Today - HPBL
ATTENTION Applied Therapeutics, Inc. Investors: You May Have Been Affected by FraudContact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire
APLT stock touches 52-week low at $0.54 amid sharp annual decline By Investing.com - Investing.com South Africa
APLT stock touches 52-week low at $0.54 amid sharp annual decline - Investing.com
Applied Therapeutics Inc (APLT) At $0.58 Is Well Worth Your Time - Stocks Register
Applied Therapeutics, Inc. (NASDAQ:APLT) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
2025-02-18 | Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. LawsuitAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
Shareholders of Applied Therapeutics, Inc. Should Contact The Gross Law Firm Before February 18, 2025 to Discuss Your RightsAPLT - PR Newswire
Applied Therapeutics, Inc. Sued for Securities Law - GlobeNewswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics - Business Wire
DEADLINE ALERT for APLT and KSPI: The Law Offices of Frank - GlobeNewswire
Applied Therapeutics Inc (APLT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.00%
자본화:
|
볼륨(24시간):